25 XP   0   0   10

Integrated Biopharma Inc
Buy, Hold or Sell?

Let's analyse Integrated Biopharma Inc together

PenkeI guess you are interested in Integrated Biopharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Integrated Biopharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Integrated Biopharma Inc

I send you an email if I find something interesting about Integrated Biopharma Inc.

Quick analysis of Integrated Biopharma Inc (30 sec.)










What can you expect buying and holding a share of Integrated Biopharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.63
Expected worth in 1 year
$0.68
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
$0.06
Return On Investment
22.6%

For what price can you sell your share?

Current Price per Share
$0.26
Expected price per share
$0 - $0.27
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Integrated Biopharma Inc (5 min.)




Live pricePrice per Share (EOD)

$0.26

Intrinsic Value Per Share

$-1.14 - $1.33

Total Value Per Share

$-0.51 - $1.96

2. Growth of Integrated Biopharma Inc (5 min.)




Is Integrated Biopharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$18.7m$15.5m$3m16.5%

How much money is Integrated Biopharma Inc making?

Current yearPrevious yearGrowGrow %
Making money$355k$1.7m-$1.3m-382.5%
Net Profit Margin2.7%10.7%--

How much money comes from the company's main activities?

3. Financial Health of Integrated Biopharma Inc (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  


Richest
#411 / 506

Most Revenue
#417 / 506

Most Profit
#335 / 506

Most Efficient
#245 / 506
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Integrated Biopharma Inc? (5 min.)

Welcome investor! Integrated Biopharma Inc's management wants to use your money to grow the business. In return you get a share of Integrated Biopharma Inc.

What can you expect buying and holding a share of Integrated Biopharma Inc?

First you should know what it really means to hold a share of Integrated Biopharma Inc. And how you can make/lose money.

Speculation

The Price per Share of Integrated Biopharma Inc is $0.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Integrated Biopharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Integrated Biopharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.63. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Integrated Biopharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.2%0.014.6%0.0622.0%0.0311.8%0.027.5%
Usd Book Value Change Per Share0.001.1%0.015.6%0.0623.2%0.0415.9%0.029.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.001.1%0.015.6%0.0623.2%0.0415.9%0.029.6%
Usd Price Per Share0.38-0.42-1.00-0.50-0.33-
Price to Earnings Ratio177.83-9.64-8.00-5.79-2.78-
Price-to-Total Gains Ratio127.87-190.48-29.04-51.02-13.39-
Price to Book Ratio0.61-0.67-1.93-3.34-1.37-
Price-to-Total Gains Ratio127.87-190.48-29.04-51.02-13.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.26
Number of shares3846
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.04
Usd Total Gains Per Share0.010.04
Gains per Quarter (3846 shares)56.39159.24
Gains per Year (3846 shares)225.57636.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102262160637627
20451442012741264
30677668019111901
40902894025482538
5011281120031853175
6013531346038223812
7015791572044594449
8018051798050965086
9020302024057335723
10022562250063706360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%18.02.00.090.0%30.09.01.075.0%49.09.034.053.3%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%32.08.00.080.0%56.036.00.060.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%17.00.075.018.5%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%32.08.00.080.0%56.036.00.060.9%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Integrated Biopharma Inc

About Integrated Biopharma Inc

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Fundamental data was last updated by Penke on 2023-09-19 03:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Integrated Biopharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Integrated Biopharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • A Net Profit Margin of 0.1% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Integrated Biopharma Inc:

  • The MRQ is 0.1%. The company is not making a profit/loss.
  • The TTM is 2.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM2.7%-2.5%
TTM2.7%YOY10.7%-8.0%
TTM2.7%5Y6.3%-3.6%
5Y6.3%10Y4.3%+2.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%2.9%-2.8%
TTM2.7%2.7%0.0%
YOY10.7%3.3%+7.4%
5Y6.3%3.5%+2.8%
10Y4.3%3.7%+0.6%
1.1.2. Return on Assets

Shows how efficient Integrated Biopharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • 0.1% Return on Assets means that Integrated Biopharma Inc generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Integrated Biopharma Inc:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.1%TTM1.4%-1.3%
TTM1.4%YOY6.6%-5.2%
TTM1.4%5Y3.9%-2.5%
5Y3.9%10Y2.8%+1.1%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%1.0%-0.9%
TTM1.4%1.1%+0.3%
YOY6.6%1.1%+5.5%
5Y3.9%1.2%+2.7%
10Y2.8%1.2%+1.6%
1.1.3. Return on Equity

Shows how efficient Integrated Biopharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • 0.1% Return on Equity means Integrated Biopharma Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Integrated Biopharma Inc:

  • The MRQ is 0.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM1.9%-1.8%
TTM1.9%YOY11.5%-9.6%
TTM1.9%5Y20.7%-18.8%
5Y20.7%10Y14.5%+6.1%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%2.1%-2.0%
TTM1.9%2.2%-0.3%
YOY11.5%2.5%+9.0%
5Y20.7%2.6%+18.1%
10Y14.5%2.6%+11.9%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Integrated Biopharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Integrated Biopharma Inc is operating .

  • Measures how much profit Integrated Biopharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Integrated Biopharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.9%-0.9%
TTM0.9%YOY8.4%-7.5%
TTM0.9%5Y6.0%-5.1%
5Y6.0%10Y4.9%+1.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.3%-4.3%
TTM0.9%2.1%-1.2%
YOY8.4%4.9%+3.5%
5Y6.0%5.2%+0.8%
10Y4.9%4.5%+0.4%
1.2.2. Operating Ratio

Measures how efficient Integrated Biopharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 1.92 means that the operating costs are $1.92 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 1.920. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.903. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.920TTM1.903+0.016
TTM1.903YOY1.351+0.552
TTM1.9035Y0.768+1.135
5Y0.76810Y0.854-0.086
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9201.533+0.387
TTM1.9031.529+0.374
YOY1.3511.484-0.133
5Y0.7681.445-0.677
10Y0.8541.235-0.381
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Integrated Biopharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Integrated Biopharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 2.84 means the company has $2.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 2.842. The company is able to pay all its short-term debts. +1
  • The TTM is 3.024. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.842TTM3.024-0.181
TTM3.024YOY2.097+0.927
TTM3.0245Y1.725+1.299
5Y1.72510Y1.283+0.441
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8421.570+1.272
TTM3.0241.598+1.426
YOY2.0971.621+0.476
5Y1.7251.652+0.073
10Y1.2831.564-0.281
1.3.2. Quick Ratio

Measures if Integrated Biopharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • A Quick Ratio of 0.76 means the company can pay off $0.76 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 0.760. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.799. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.760TTM0.799-0.039
TTM0.799YOY0.687+0.113
TTM0.7995Y0.525+0.275
5Y0.52510Y0.430+0.095
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7600.566+0.194
TTM0.7990.585+0.214
YOY0.6870.661+0.026
5Y0.5250.692-0.167
10Y0.4300.706-0.276
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Integrated Biopharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Integrated Biopharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Integrated Biopharma Inc to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 0.30 means that Integrated Biopharma Inc assets are financed with 30.3% credit (debt) and the remaining percentage (100% - 30.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 0.303. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.286. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.303TTM0.286+0.017
TTM0.286YOY0.405-0.118
TTM0.2865Y0.660-0.374
5Y0.66010Y1.158-0.498
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3030.492-0.189
TTM0.2860.490-0.204
YOY0.4050.479-0.074
5Y0.6600.488+0.172
10Y1.1580.491+0.667
1.4.2. Debt to Equity Ratio

Measures if Integrated Biopharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 43.4% means that company has $0.43 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 0.434. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.402. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.434TTM0.402+0.033
TTM0.402YOY0.681-0.280
TTM0.4025Y10.119-9.717
5Y10.11910Y6.830+3.289
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4340.963-0.529
TTM0.4020.962-0.560
YOY0.6810.907-0.226
5Y10.1190.992+9.127
10Y6.8301.076+5.754
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Integrated Biopharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Integrated Biopharma Inc generates.

  • Above 15 is considered overpriced but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • A PE ratio of 177.83 means the investor is paying $177.83 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Integrated Biopharma Inc:

  • The EOD is 121.670. Based on the earnings, the company is expensive. -2
  • The MRQ is 177.826. Based on the earnings, the company is expensive. -2
  • The TTM is 9.639. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD121.670MRQ177.826-56.156
MRQ177.826TTM9.639+168.187
TTM9.639YOY8.005+1.634
TTM9.6395Y5.793+3.846
5Y5.79310Y2.776+3.017
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD121.67012.202+109.468
MRQ177.82611.543+166.283
TTM9.63912.807-3.168
YOY8.00512.798-4.793
5Y5.79316.405-10.612
10Y2.77618.926-16.150
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Integrated Biopharma Inc:

  • The EOD is 1.339. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.957. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -6.906. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.339MRQ1.957-0.618
MRQ1.957TTM-6.906+8.863
TTM-6.906YOY6.161-13.067
TTM-6.9065Y-0.118-6.788
5Y-0.11810Y0.216-0.335
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD1.3393.790-2.451
MRQ1.9573.722-1.765
TTM-6.9061.178-8.084
YOY6.1610.159+6.002
5Y-0.1181.723-1.841
10Y0.2161.401-1.185
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Integrated Biopharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 0.61 means the investor is paying $0.61 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Integrated Biopharma Inc:

  • The EOD is 0.416. Based on the equity, the company is cheap. +2
  • The MRQ is 0.607. Based on the equity, the company is cheap. +2
  • The TTM is 0.671. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.416MRQ0.607-0.192
MRQ0.607TTM0.671-0.064
TTM0.671YOY1.934-1.264
TTM0.6715Y3.340-2.669
5Y3.34010Y1.371+1.969
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD0.4161.581-1.165
MRQ0.6071.525-0.918
TTM0.6711.551-0.880
YOY1.9341.987-0.053
5Y3.3402.034+1.306
10Y1.3712.533-1.162
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Integrated Biopharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0030.015-80%0.060-95%0.041-93%0.025-88%
Book Value Per Share--0.6260.623+1%0.520+20%0.295+112%0.005+12859%
Current Ratio--2.8423.024-6%2.097+36%1.725+65%1.283+121%
Debt To Asset Ratio--0.3030.286+6%0.405-25%0.660-54%1.158-74%
Debt To Equity Ratio--0.4340.402+8%0.681-36%10.119-96%6.830-94%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0010.012-95%0.057-99%0.031-98%0.020-97%
Free Cash Flow Per Share--0.0490.042+17%0.013+286%0.016+206%0.013+277%
Free Cash Flow To Equity Per Share--0.0480.019+155%0.001+4083%0.004+1183%0.006+688%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--1.333--------
Intrinsic Value_10Y_min---1.139--------
Intrinsic Value_1Y_max--0.081--------
Intrinsic Value_1Y_min--0.024--------
Intrinsic Value_3Y_max--0.282--------
Intrinsic Value_3Y_min---0.048--------
Intrinsic Value_5Y_max--0.533--------
Intrinsic Value_5Y_min---0.249--------
Market Cap7782554.000-46%11380851.80012503962.175-9%29783235.500-62%14978770.794-24%9926372.450+15%
Net Profit Margin--0.0010.027-95%0.107-99%0.063-98%0.043-97%
Operating Margin---0.009-100%0.084-100%0.060-100%0.049-100%
Operating Ratio--1.9201.903+1%1.351+42%0.768+150%0.854+125%
Pb Ratio0.416-46%0.6070.671-9%1.934-69%3.340-82%1.371-56%
Pe Ratio121.670-46%177.8269.639+1745%8.005+2121%5.793+2969%2.776+6305%
Price Per Share0.260-46%0.3800.418-9%0.995-62%0.500-24%0.332+15%
Price To Free Cash Flow Ratio1.339-46%1.957-6.906+453%6.161-68%-0.118+106%0.216+804%
Price To Total Gains Ratio87.493-46%127.875190.476-33%29.035+340%51.023+151%13.394+855%
Quick Ratio--0.7600.799-5%0.687+11%0.525+45%0.430+77%
Return On Assets--0.0010.014-96%0.066-99%0.039-98%0.028-98%
Return On Equity--0.0010.019-96%0.115-99%0.207-100%0.145-99%
Total Gains Per Share--0.0030.015-80%0.060-95%0.041-93%0.025-88%
Usd Book Value--18741000.00018647250.000+1%15567500.000+20%8824450.000+112%145575.000+12774%
Usd Book Value Change Per Share--0.0030.015-80%0.060-95%0.041-93%0.025-88%
Usd Book Value Per Share--0.6260.623+1%0.520+20%0.295+112%0.005+12859%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0010.012-95%0.057-99%0.031-98%0.020-97%
Usd Free Cash Flow--1454000.0001247000.000+17%376000.000+287%475650.000+206%375800.000+287%
Usd Free Cash Flow Per Share--0.0490.042+17%0.013+286%0.016+206%0.013+277%
Usd Free Cash Flow To Equity Per Share--0.0480.019+155%0.001+4083%0.004+1183%0.006+688%
Usd Market Cap7782554.000-46%11380851.80012503962.175-9%29783235.500-62%14978770.794-24%9926372.450+15%
Usd Price Per Share0.260-46%0.3800.418-9%0.995-62%0.500-24%0.332+15%
Usd Profit--16000.000355000.000-95%1712750.000-99%919550.000-98%584425.000-97%
Usd Revenue--13098000.00012736250.000+3%15009250.000-13%13639700.000-4%11846850.000+11%
Usd Total Gains Per Share--0.0030.015-80%0.060-95%0.041-93%0.025-88%
 EOD+4 -4MRQTTM+11 -22YOY+16 -175Y+15 -1810Y+19 -15

3.2. Fundamental Score

Let's check the fundamental score of Integrated Biopharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15121.670
Price to Book Ratio (EOD)Between0-10.416
Net Profit Margin (MRQ)Greater than00.001
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.760
Current Ratio (MRQ)Greater than12.842
Debt to Asset Ratio (MRQ)Less than10.303
Debt to Equity Ratio (MRQ)Less than10.434
Return on Equity (MRQ)Greater than0.150.001
Return on Assets (MRQ)Greater than0.050.001
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Integrated Biopharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.347
Ma 20Greater thanMa 500.288
Ma 50Greater thanMa 1000.300
Ma 100Greater thanMa 2000.322
OpenGreater thanClose0.191
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets26,880
Total Liabilities8,139
Total Stockholder Equity18,741
 As reported
Total Liabilities 8,139
Total Stockholder Equity+ 18,741
Total Assets = 26,880

Assets

Total Assets26,880
Total Current Assets17,508
Long-term Assets17,508
Total Current Assets
Cash And Cash Equivalents 2,529
Net Receivables 4,683
Inventory 9,937
Other Current Assets 359
Total Current Assets  (as reported)17,508
Total Current Assets  (calculated)17,508
+/-0
Long-term Assets
Long-term Assets Other 58
Long-term Assets  (as reported)9,372
Long-term Assets  (calculated)58
+/- 9,314

Liabilities & Shareholders' Equity

Total Current Liabilities6,160
Long-term Liabilities1,979
Total Stockholder Equity18,741
Total Current Liabilities
Accounts payable 3,533
Total Current Liabilities  (as reported)6,160
Total Current Liabilities  (calculated)3,533
+/- 2,627
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,899
Long-term Liabilities  (as reported)1,979
Long-term Liabilities  (calculated)2,899
+/- 920
Total Stockholder Equity
Total Stockholder Equity (as reported)18,741
Total Stockholder Equity (calculated)0
+/- 18,741
Other
Capital Stock60
Common Stock Shares Outstanding 29,950
Net Invested Capital 18,741
Net Working Capital 11,348



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
10,400
8,580
9,748
10,135
9,984
9,838
10,604
9,964
9,338
10,007
9,925
11,192
12,447
20,827
22,358
24,480
24,503
31,813
30,170
28,234
31,227
26,242
27,964
29,527
30,810
37,605
40,155
41,843
43,610
44,209
46,564
42,087
34,892
31,357
30,165
22,647
19,781
16,483
16,195
16,627
14,503
13,848
13,401
13,660
13,228
13,650
13,409
11,530
10,752
11,877
12,174
13,587
12,727
12,611
12,567
11,766
10,322
11,583
13,144
13,661
12,420
11,623
12,077
14,220
14,112
14,085
14,647
14,998
13,614
15,196
13,381
15,648
14,621
14,568
19,724
22,575
22,221
19,790
19,641
19,971
20,645
22,944
24,630
25,263
26,131
25,440
24,336
27,071
27,697
25,250
26,364
26,052
26,880
26,88026,05226,36425,25027,69727,07124,33625,44026,13125,26324,63022,94420,64519,97119,64119,79022,22122,57519,72414,56814,62115,64813,38115,19613,61414,99814,64714,08514,11214,22012,07711,62312,42013,66113,14411,58310,32211,76612,56712,61112,72713,58712,17411,87710,75211,53013,40913,65013,22813,66013,40113,84814,50316,62716,19516,48319,78122,64730,16531,35734,89242,08746,56444,20943,61041,84340,15537,60530,81029,52727,96426,24231,22728,23430,17031,81324,50324,48022,35820,82712,44711,1929,92510,0079,3389,96410,6049,8389,98410,1359,7488,58010,400
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,698
0
0
0
0
0
0
0
0
9,239
7,846
9,166
10,486
11,117
9,994
9,322
9,833
11,939
11,730
12,070
12,704
13,087
11,636
12,551
10,635
13,212
12,294
12,154
13,733
16,540
16,350
14,079
14,083
14,536
15,297
16,461
18,574
19,099
20,526
17,998
16,984
19,347
20,043
16,626
17,063
16,385
17,508
17,50816,38517,06316,62620,04319,34716,98417,99820,52619,09918,57416,46115,29714,53614,08314,07916,35016,54013,73312,15412,29413,21210,63512,55111,63613,08712,70412,07011,73011,9399,8339,3229,99411,11710,4869,1667,8469,2390000000011,6980000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,201
5,628
1,308
2,156
1,524
3,880
1,583
873
1,082
381
781
570
1,987
1,518
735
648
1,048
1,583
606
563
1,386
388
649
145
216
124
285
55
480
819
868
983
826
580
886
572
585
561
951
896
593
567
697
597
284
54
62
228
365
45
431
475
525
67
565
402
369
43
105
210
57
162
264
331
1,168
1,085
2,529
2,5291,0851,168331264162572101054336940256567525475431453652286254284597697567593896951561585572886580826983868819480552851242161456493881,3865636061,5831,0486487351,5181,9875707813811,0828731,5833,8801,5242,1561,3085,6282,20100000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,000
2,000
0
0
2,000
0
0
0
0
0
0
0
0
0
0
0
0
0
823
823
823
823
823
823
823
684
684
684
684
684
532
532
532
532
501
501
501
501
501
501
501
501
465
382
215
263
196
0
0
0
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000008400019626321538246550150150150150150150150153253253253268468468468468482382382382382382382300000000000002,000002,0002,0002,00000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,960
0
0
0
0
0
0
0
0
2,289
1,940
2,179
2,297
3,385
2,788
2,638
2,803
3,991
3,634
3,135
3,765
4,420
2,706
4,843
2,673
5,171
3,198
4,467
3,381
4,517
4,957
4,973
3,904
4,879
4,272
5,507
4,855
4,537
7,917
9,044
3,801
5,467
6,170
4,888
3,711
4,509
4,683
4,6834,5093,7114,8886,1705,4673,8019,0447,9174,5374,8555,5074,2724,8793,9044,9734,9574,5173,3814,4673,1985,1712,6734,8432,7064,4203,7653,1353,6343,9912,8032,6382,7883,3852,2972,1791,9402,289000000001,9600000000000000000000000000000000000000000000000
       Other Current Assets 
358
390
456
486
542
392
983
403
384
170
257
333
886
806
2,319
4,215
2,436
1,281
1,752
1,439
1,576
822
638
627
1,346
4,508
4,823
4,670
4,751
4,175
4,153
5,499
3,560
1,958
2,350
953
1,080
754
699
783
649
556
560
482
3,337
3,895
3,843
3,538
454
391
439
332
344
339
342
331
370
306
389
1,463
1,210
334
522
368
1,211
518
673
686
353
510
636
505
479
481
387
443
413
461
407
3,353
394
317
594
603
3,050
2,749
504
597
513
340
516
527
359
3595275163405135975042,7493,0506035943173943,3534074614134433874814795056365103536866735181,2113685223341,2101,4633893063703313423393443324393914543,5383,8433,8953,3374825605566497836997541,0809532,3501,9583,5605,4994,1534,1754,7514,6704,8234,5081,3466276388221,5761,4391,7521,2812,4364,2152,319806886333257170384403983392542486456390358
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,711
0
0
0
0
0
0
0
0
2,527
2,476
2,417
2,658
1,483
1,649
2,301
2,080
2,281
1,486
1,780
1,536
1,498
1,978
1,601
2,746
1,860
2,327
1,651
2,365
2,522
2,472
5,062
4,914
2,383
596
6,483
1,606
1,857
1,637
1,742
7,352
7,724
7,654
8,624
9,301
9,667
9,372
9,3729,6679,3018,6247,6547,7247,3521,7421,6371,8571,6066,4835962,3834,9145,0622,4722,5222,3651,6512,3271,8602,7461,6011,9781,4981,5361,7801,4862,2812,0802,3011,6491,4832,6582,4172,4762,527000000001,7110000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,409
1,367
2,574
2,502
2,438
2,350
2,364
2,328
2,346
2,308
2,436
2,360
2,325
2,294
5,156
5,943
6,785
6,857
7,677
7,546
7,451
4,664
4,510
4,350
4,222
4,173
4,066
4,084
4,168
4,377
4,275
4,132
3,942
3,886
3,688
3,442
1,940
1,865
1,824
1,859
1,790
1,719
1,780
1,768
1,631
1,598
1,519
1,445
1,466
1,449
1,359
1,289
1,299
1,235
1,168
1,205
1,231
1,239
1,531
1,483
1,431
1,373
1,368
1,488
1,486
1,567
1,536
1,498
1,654
1,601
1,632
1,684
1,670
1,651
1,604
1,806
1,802
1,778
1,745
1,720
1,698
4,520
1,670
1,651
1,637
1,742
3,982
3,913
3,931
3,777
4,496
0
0
004,4963,7773,9313,9133,9821,7421,6371,6511,6704,5201,6981,7201,7451,7781,8021,8061,6041,6511,6701,6841,6321,6011,6541,4981,5361,5671,4861,4881,3681,3731,4311,4831,5311,2391,2311,2051,1681,2351,2991,2891,3591,4491,4661,4451,5191,5981,6311,7681,7801,7191,7901,8591,8241,8651,9403,4423,6883,8863,9424,1324,2754,3774,1684,0844,0664,1734,2224,3504,5104,6647,4517,5467,6776,8576,7855,9435,1562,2942,3252,3602,4362,3082,3462,3282,3642,3502,4382,5022,5741,3671,409
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,643
688
688
688
688
145
145
145
145
145
145
145
145
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000001451451451451451451451456886886886881,6430000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
507
497
487
1,020
3,678
4,167
4,247
4,178
4,639
4,532
3,618
3,547
3,721
3,820
4,161
4,111
4,056
5,531
6,263
6,114
6,106
6,051
5,165
1,743
1,683
1,631
1,570
1,535
1,501
1,466
1,432
1,397
1,363
0
0
0
0
1,188
1,154
1,119
1,085
1,051
1,017
983
948
914
880
846
811
777
743
712
688
663
235
0
0
0
134
0
0
0
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000330001340002356636887127437778118468809149489831,0171,0511,0851,1191,1541,18800001,3631,3971,4321,4661,5011,5351,5701,6311,6831,7435,1656,0516,1066,1146,2635,5314,0564,1114,1613,8203,7213,5473,6184,5324,6394,1784,2474,1673,6781,02048749750700000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
192
0
0
0
0
0
0
0
0
374
331
298
281
0
218
185
0
105
0
213
0
0
324
0
237
176
124
0
121
57
48
3,284
3,169
86
3,054
2,824
2,780
2,656
0
0
0
0
53
49
44
61
58
586144495300002,6562,7802,8243,054863,1693,28448571210124176237032400213010501852180281298331374000000001920000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
877
0
533
0
640
659
622
0
0
577
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000057700622659640053308770000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
3,521
2,207
2,452
3,459
3,613
3,646
3,591
2,743
1,976
2,422
2,154
3,094
2,773
2,572
7,745
7,939
9,062
7,416
7,463
7,816
9,395
10,272
10,028
10,322
11,234
11,872
13,900
20,493
20,866
24,212
27,733
25,919
18,579
20,494
18,373
18,487
19,139
18,929
17,928
19,074
18,702
19,544
18,928
19,538
19,959
21,345
20,731
19,629
19,585
22,260
23,529
24,125
23,797
22,901
22,559
21,360
20,366
21,738
22,896
22,864
21,729
20,939
21,142
23,341
23,193
22,412
22,321
22,728
21,091
21,125
19,485
22,095
20,677
19,804
19,529
22,109
20,832
17,897
17,421
16,777
16,501
16,877
17,514
16,830
16,382
11,106
9,445
11,001
10,722
6,675
7,743
7,400
8,139
8,1397,4007,7436,67510,72211,0019,44511,10616,38216,83017,51416,87716,50116,77717,42117,89720,83222,10919,52919,80420,67722,09519,48521,12521,09122,72822,32122,41223,19323,34121,14220,93921,72922,86422,89621,73820,36621,36022,55922,90123,79724,12523,52922,26019,58519,62920,73121,34519,95919,53818,92819,54418,70219,07417,92818,92919,13918,48718,37320,49418,57925,91927,73324,21220,86620,49313,90011,87211,23410,32210,02810,2729,3957,8167,4637,4169,0627,9397,7452,5722,7733,0942,1542,4221,9762,7433,5913,6463,6133,4592,4522,2073,521
   > Total Current Liabilities 
3,480
1,629
2,407
3,418
3,585
3,553
3,569
2,725
1,962
2,412
2,149
3,089
2,768
2,572
7,573
7,939
9,062
7,416
7,463
7,816
9,395
10,272
10,028
10,322
11,234
11,872
13,900
20,493
20,866
15,862
19,483
25,919
14,864
10,038
7,729
14,579
15,166
14,890
15,088
15,983
18,702
19,544
18,928
19,538
19,959
21,345
20,731
19,629
19,585
12,203
12,496
13,192
12,766
12,416
12,117
11,071
10,207
11,653
12,933
13,441
12,542
11,865
12,149
14,362
12,304
11,824
11,791
11,988
10,536
11,155
9,865
12,531
11,313
16,180
12,576
15,511
14,437
12,353
12,542
12,293
12,388
13,099
14,644
14,265
14,372
9,236
7,701
9,384
9,233
5,263
5,814
5,188
6,160
6,1605,1885,8145,2639,2339,3847,7019,23614,37214,26514,64413,09912,38812,29312,54212,35314,43715,51112,57616,18011,31312,5319,86511,15510,53611,98811,79111,82412,30414,36212,14911,86512,54213,44112,93311,65310,20711,07112,11712,41612,76613,19212,49612,20319,58519,62920,73121,34519,95919,53818,92819,54418,70215,98315,08814,89015,16614,5797,72910,03814,86425,91919,48315,86220,86620,49313,90011,87211,23410,32210,02810,2729,3957,8167,4637,4169,0627,9397,5732,5722,7683,0892,1492,4121,9622,7253,5693,5533,5853,4182,4071,6293,480
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,305
0
0
0
0
0
0
0
0
4,832
4,017
4,709
5,335
6,205
5,240
5,193
4,926
6,689
5,040
5,220
5,844
5,758
5,454
5,794
5,556
6,095
5,553
5,667
5,550
7,229
7,161
5,834
4,799
6,337
4,574
6,869
5,659
6,331
5,687
3,630
0
0
0
0
0
0
0
00000003,6305,6876,3315,6596,8694,5746,3374,7995,8347,1617,2295,5505,6675,5536,0955,5565,7945,4545,7585,8445,2205,0406,6894,9265,1935,2406,2055,3354,7094,0174,8320000000012,3050000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,950
4,739
15,261
1,031
869
852
6,042
851
903
7,161
6,881
5,852
6,337
4,574
6,869
5,659
6,331
5,687
3,630
1,509
3,158
2,728
133
0
0
0
0001332,7283,1581,5093,6305,6876,3315,6596,8694,5746,3375,8526,8817,1619038516,0428528691,03115,2614,7394,9500000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
2,527
1,358
1,062
2,054
2,261
2,176
2,118
1,993
1,550
1,632
1,366
2,408
2,182
1,978
2,293
2,482
3,617
1,937
1,875
2,257
3,507
3,987
3,902
3,710
5,205
4,124
5,913
3,896
3,558
3,594
5,551
5,766
4,300
6,630
4,503
5,143
6,355
5,788
5,153
5,915
5,672
6,440
5,264
5,659
4,175
5,152
5,608
3,366
4,839
6,481
6,407
7,028
6,520
5,883
5,625
6,239
6,190
6,944
7,598
7,236
7,302
11,804
7,223
12,858
12,460
11,886
5,947
12,263
5,797
5,361
10,163
12,117
11,399
10,513
7,026
8,282
7,276
3,855
5,106
5,478
7,330
4,358
8,491
7,441
8,190
5,106
4,221
4,243
4,690
3,209
3,529
2,856
3,533
3,5332,8563,5293,2094,6904,2434,2215,1068,1907,4418,4914,3587,3305,4785,1063,8557,2768,2827,02610,51311,39912,11710,1635,3615,79712,2635,94711,88612,46012,8587,22311,8047,3027,2367,5986,9446,1906,2395,6255,8836,5207,0286,4076,4814,8393,3665,6085,1524,1755,6595,2646,4405,6725,9155,1535,7886,3555,1434,5036,6304,3005,7665,5513,5943,5583,8965,9134,1245,2053,7103,9023,9873,5072,2571,8751,9373,6172,4822,2931,9782,1822,4081,3661,6321,5501,9932,1182,1762,2612,0541,0621,3582,527
       Other Current Liabilities 
376
221
300
447
506
644
413
406
156
656
647
638
577
540
649
633
684
732
834
857
1,187
1,613
1,454
1,940
1,357
2,505
2,336
2,222
2,897
3,574
3,676
3,048
3,422
3,328
3,226
2,420
1,579
1,644
2,246
1,963
1,571
1,357
1,562
1,476
3,179
3,588
2,818
3,658
2,141
1,549
1,594
1,438
1,296
1,122
1,279
1,190
1,284
1,309
1,199
1,291
1,474
3,942
1,189
3,794
5,554
1,211
1,118
4,707
1,120
1,184
3,766
3,883
1,264
3,624
0
0
0
5,544
0
3,058
484
488
494
3,058
495
2,370
0
0
0
0
0
0
0
00000002,3704953,0584944884843,05805,5440003,6241,2643,8833,7661,1841,1204,7071,1181,2115,5543,7941,1893,9421,4741,2911,1991,3091,2841,1901,2791,1221,2961,4381,5941,5492,1413,6582,8183,5883,1791,4761,5621,3571,5711,9632,2461,6441,5792,4203,2263,3283,4223,0483,6763,5742,8972,2222,3362,5051,3571,9401,4541,6131,187857834732684633649540577638647656156406413644506447300221376
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,289
10,159
10,085
9,963
9,423
9,187
0
8,993
0
139
5,306
10,530
0
9,840
9,970
0
0
3,725
0
3,319
3,077
2,988
5,544
4,879
1,904
4,113
3,778
2,870
2,565
2,010
1,870
1,744
1,617
1,489
1,412
1,929
2,212
1,979
1,9792,2121,9291,4121,4891,6171,7441,8702,0102,5652,8703,7784,1131,9044,8795,5442,9883,0773,31903,725009,9709,840010,5305,30613908,99309,1879,4239,96310,08510,15910,2890000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,647
4,500
4,359
4,423
4,302
4,080
0
3,830
0
0
5,306
4,870
0
4,605
4,246
0
0
3,725
0
3,319
3,077
2,988
0
2,177
1,904
1,648
1,436
654
0
40
0
0
0
0
0
0
0
0
000000004006541,4361,6481,9042,17702,9883,0773,31903,725004,2464,60504,8705,306003,83004,0804,3024,4234,3594,5004,6470000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
877
0
533
0
640
659
622
0
0
577
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000057700622659640053308770000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
69
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
350
250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
563
1,648
991
1,165
696
770
687
677
717
503
56
15
12
15
9
139
76
444
808
715
503
621
436
382
0
0
0
0
2,822
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002,8220000382436621503715808444761399151215565037176776877706961,1659911,648563000000000000000000250350000000000000000000000006900000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
687
677
717
503
56
15
0
15
0
139
0
444
0
0
503
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000503004440139015015565037176776870000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
6,879
6,373
7,296
6,676
6,371
6,192
7,013
7,221
7,362
7,585
7,771
8,098
9,674
18,255
14,613
16,541
15,441
24,397
22,707
20,047
21,461
15,621
17,619
18,972
19,365
25,577
26,137
21,350
22,744
19,997
18,831
16,168
16,313
10,863
11,792
4,160
642
0
0
0
0
0
0
0
0
0
-7,322
0
0
0
0
0
0
0
0
-9,594
-10,044
-10,155
-9,752
-9,203
-9,309
-9,316
-9,065
-9,121
-9,081
-8,327
-7,674
-7,730
-7,477
-5,929
-6,104
-6,447
-6,056
-5,236
195
466
1,389
1,893
2,220
3,194
4,144
6,067
7,116
8,433
9,749
14,334
14,891
16,070
16,975
18,575
18,621
18,652
18,741
18,74118,65218,62118,57516,97516,07014,89114,3349,7498,4337,1166,0674,1443,1942,2201,8931,389466195-5,236-6,056-6,447-6,104-5,929-7,477-7,730-7,674-8,327-9,081-9,121-9,065-9,316-9,309-9,203-9,752-10,155-10,044-9,59400000000-7,3220000000006424,16011,79210,86316,31316,16818,83119,99722,74421,35026,13725,57719,36518,97217,61915,62121,46120,04722,70724,39715,44116,54114,61318,2559,6748,0987,7717,5857,3627,2217,0136,1926,3716,6767,2966,3736,879
   Common Stock
10
10
12
13
13
12
12
12
12
12
12
12
20
20
21
21
21
25
25
25
25
25
25
25
26
26
27
27
28
28
28
29
29
30
40
40
40
40
40
41
41
41
41
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
59
59
59
59
59
59
59
59
59
59
60
60
60
60
60
60
60
0
0
0060606060606060595959595959595959594242424242424242424242424242424242424242424242424242424242424241414141404040404030292928282827272626252525252525252121212020121212121212121313121010
   Retained Earnings 
2,021
1,544
1,218
597
283
95
916
1,124
1,265
1,488
1,674
2,001
2,219
2,382
1,530
1,068
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-51,818
0
0
0
0
0
0
0
0
-54,105
-54,555
-54,670
-54,267
-53,718
-53,824
-53,935
-53,692
-53,756
-53,723
-52,977
-52,328
-52,405
-52,167
-50,631
-50,810
-51,158
-50,770
-49,952
-49,793
-49,547
-48,624
-48,264
-47,952
-46,993
-46,057
-44,156
-43,115
-41,891
-40,650
-36,143
-35,627
-34,596
-33,799
-32,305
-32,340
-32,395
-32,379
-32,379-32,395-32,340-32,305-33,799-34,596-35,627-36,143-40,650-41,891-43,115-44,156-46,057-46,993-47,952-48,264-48,624-49,547-49,793-49,952-50,770-51,158-50,810-50,631-52,167-52,405-52,328-52,977-53,723-53,756-53,692-53,935-53,824-53,718-54,267-54,670-54,555-54,10500000000-51,8180000000000000000000000000000001,0681,5302,3822,2192,0011,6741,4881,2651,124916952835971,2181,5442,021
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,553
0
0
0
0
0
0
0
0
44,568
44,568
44,572
44,572
44,572
44,572
44,676
44,684
44,692
44,699
44,707
44,711
44,732
44,747
44,759
44,763
44,768
44,771
44,773
50,028
50,053
50,053
50,197
50,212
50,227
50,241
50,263
50,271
50,364
50,438
50,516
0
0
0
0
0
0
0
000000050,51650,43850,36450,27150,26350,24150,22750,21250,19750,05350,05350,02844,77344,77144,76844,76344,75944,74744,73244,71144,70744,69944,69244,68444,67644,57244,57244,57244,57244,56844,5680000000044,5530000000000000000000000000000000000000000000000
   Treasury Stock0000000-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-29-29-29-29-29-29-29-28-29-29-29-29-29-29-29-29-290
   Other Stockholders Equity 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.